about
Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translationA promoter activity is present in the DNA sequence corresponding to the hepatitis C virus 5' UTRA functional selection of viral genetic elements in cultured cells to identify hepatitis C virus RNA translation inhibitorsCellular internalization of water-soluble helical aromatic amide foldamers.Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori InfectionIdentification of a structural element of the hepatitis C virus minus strand RNA involved in the initiation of RNA synthesisHelicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells.Targeting the production of oncogenic microRNAs with multimodal synthetic small molecules.Helicobacter pylori interferes with an embryonic stem cell micro RNA cluster to block cell cycle progression.Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.Deletion of IQGAP1 promotes Helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro.Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.MicroRNAs and bacterial infection.High-efficiency transfection of primary human keratinocytes with positively charged lipopolyamine:DNA complexes.Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition.Oncogenic MicroRNAs Biogenesis as a Drug Target: Structure-Activity Relationship Studies on New Aminoglycoside Conjugates.Helicobacter pylori generates cells with cancer stem cell properties via epithelial-mesenchymal transition-like changes.Regulating mRNA translation with a kiss.Lipid-conjugated oligonucleotides via "click chemistry" efficiently inhibit hepatitis C virus translation.Altered adhesion properties and alphav integrin expression in a cisplatin-resistant human ovarian carcinoma cell line.Glycosyl-nucleoside-lipid based supramolecular assembly as a nanostructured material with nucleic acid delivery capabilities.[Integrins, cell response to anti-tumor agents and chemoresistance].All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.Lipospermine-mediated gene transfer technique into murine cultured cortical cells.Encapsidation of RNA–Polyelectrolyte Complexes with Amphiphilic Block Copolymers: Toward a New Self-Assembly RouteDetergents affect insulin binding, tyrosine kinase activity and oligomeric structure of partially purified insulin receptorsLiver plasma membrane lipid composition and insulin receptor tyrosine kinase activity in HTG ratMalignant transformation in hepatocytes is associated with the general increase of glycoprotein ligands specifically binding to the endogenous lectin CSLEncapsulation of insulin for oral administration preserves interaction of the hormone with its receptor in vitro[Stimulation of antigenicity of renal adenocarcinoma cells]Increased immunogenicity of human renal carcinoma cells following treatment with cholesterol derivativesDietary PUFAs improve liver insulin receptor tyrosine kinase activity in high sucrose-fed ratsExpression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinomaThe p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cellsHuman ovarian adenocarcinoma cells synthesize vitronectin and use It to organize their adhesionDevelopment and biological assessment of fully water-soluble helical aromatic amide foldamerspH-Cleavable Nucleoside Lipids: A New Paradigm for Controlling the Stability of Lipid-Based Delivery Systems
P50
Q27473063-25E569A6-24D4-4E59-B7C6-CBBF2AB67164Q27473360-92D25A98-7963-4F45-A874-FAA02C212BF4Q27486801-CE4B4E3C-D16A-4725-941B-B37514F1362DQ33643160-EA62830E-C784-4FA8-8231-51CD9FEB8122Q33689752-628CAA46-BB52-4BCD-B5D4-5ED1210B2801Q33959374-0F1A176A-26AC-4D1B-9122-B88BB499F6BEQ34658320-9139F0F5-82E7-44B9-83B2-EAE9942E2BE6Q35073469-1C408D0C-07F1-49AE-B841-50BEA98F374CQ35540614-8EB86EC8-CFF9-45EF-AC52-DEC30748886EQ36033063-B3F8F2B3-9A96-4DE7-817D-9CA446608314Q37684660-9A9FD5C1-728F-451F-8054-E42851D8839AQ37974881-D6530EE2-A208-4654-B1F7-45E724918646Q38116527-D68001F4-0337-4F32-9316-F6F644198BB9Q38568661-C0D1562D-7B84-44AD-937E-ABF431EFF424Q38725402-1BBE6ABA-5FAE-4D8C-94A7-188E4ED526BBQ38901710-E09685DA-BF78-44EC-9C28-9611D65E043AQ39085736-8139E951-1751-49BB-B52F-8598376F52D7Q39942303-33343732-41C6-4C96-8BEB-8B1B56444E0FQ39964425-522CE4EC-E298-497B-9DBC-36043ED3A021Q40759580-AA7775A0-382E-4A85-B405-783F0B07071EQ43071158-0CF6D3C1-0D29-49EE-AAA7-7A676CD27087Q44258805-F3B41862-9788-4F06-8E62-F226FF3EF82CQ48955943-FDE718D8-7A11-42A9-9C94-603AB6BED0CDQ54571108-05A529C0-09F0-4212-A32D-74C5C7078FC3Q63973012-ADA36C28-AD92-4937-BD37-CD3A30B3F6B4Q67486876-1F1701B8-2028-49D7-84A8-E02AC5AA3384Q67490582-239134A3-13BF-415E-83DD-3AF70C932CFEQ68032832-8FC5C488-E5B0-40E0-95C3-A523E31ADBFAQ68158520-BE02B994-EEE1-4299-84DB-755BB9D86891Q68664770-AE4154CA-92B4-407E-B51D-15B2C739D3F1Q68724986-243EF811-A4F7-4941-9F13-8F097144CF3BQ70470169-21D5D856-1BD3-4CE7-B73C-A1524CE7196EQ71379886-6258905C-C750-4EC0-81B7-E7D5985660EFQ73191462-3E271CFF-A051-4368-B157-EE1293CFABF5Q74533770-1504F16E-ACC7-4C54-A5B1-5F1F397BFBA6Q80182538-978E0866-C004-4E56-AECB-6A60A9CFA428Q86184044-27F5D08C-8493-4A60-8B21-9371512EDB13
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
C Staedel
@ast
C Staedel
@en
C Staedel
@es
C Staedel
@nl
type
label
C Staedel
@ast
C Staedel
@en
C Staedel
@es
C Staedel
@nl
prefLabel
C Staedel
@ast
C Staedel
@en
C Staedel
@es
C Staedel
@nl
P106
P31
P496
0000-0003-0488-0239